Pharath Lim Selected Research

Mefloquine (Lariam)

9/2013	Therapeutic efficacy of fixed dose artesunate-mefloquine for the treatment of acute, uncomplicated Plasmodium falciparum malaria in Kampong Speu, Cambodia.
5/2010	Multiple genetic backgrounds of the amplified Plasmodium falciparum multidrug resistance (pfmdr1) gene and selective sweep of 184F mutation in Cambodia.
5/2010	Decreased in vitro susceptibility of Plasmodium falciparum isolates to artesunate, mefloquine, chloroquine, and quinine in Cambodia from 2001 to 2007.
7/2009	Artemisinin resistance in Plasmodium falciparum malaria.
1/2009	Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia.
1/2009	Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia.
4/2007	Pfmdr1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border.
12/2006	Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia.
9/2006	Surveillance of the efficacy of artesunate and mefloquine combination for the treatment of uncomplicated falciparum malaria in Cambodia.
8/2005	Countrywide survey shows very high prevalence of Plasmodium falciparum multilocus resistance genotypes in Cambodia.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pharath Lim Research Topics

Disease

21	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2022 - 08/2005
19	Malaria 01/2022 - 01/2005
6	Infections 11/2017 - 04/2007
1	Parasitemia 01/2019
1	Acute malaria 01/2015
1	Cerebral Malaria 12/2009
1	Body Weight (Weight, Body) 07/2009
1	Vivax Malaria 01/2009
1	Blister (Bulla) 09/2006

Drug/Important Bio-Agent (IBA)

15	artemisinin (artemisinine)IBA 01/2022 - 12/2005
13	ArtesunateIBA 05/2021 - 01/2005
11	Mefloquine (Lariam)FDA LinkGeneric 09/2013 - 01/2005
7	artenimol (dihydroartemisinin)IBA 01/2018 - 11/2013
5	Antimalarials (Antimalarial Agents)IBA 01/2019 - 08/2005
5	piperaquineIBA 01/2018 - 11/2013
4	Pharmaceutical PreparationsIBA 12/2013 - 09/2006
3	Lumefantrine Drug Combination Artemether (Coartem)FDA Link 05/2021 - 12/2006
2	AntibodiesIBA 01/2022 - 01/2019
2	Immunoglobulin G (IgG)IBA 01/2019 - 12/2009
1	VaccinesIBA 01/2022
1	AntigensIBA 01/2022
1	Amodiaquine (Camoquin)FDA Link 05/2021
1	Genetic Markers (Genetic Marker)IBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 02/2012
1	TESIBA 05/2010
1	CytokinesIBA 12/2009
1	AutoantibodiesIBA 12/2009
1	TubulinIBA 12/2009
1	Merozoite Surface Protein 1 (MSA1)IBA 01/2009
1	Chloroquine (Aralen)FDA LinkGeneric 01/2009
1	Drug CombinationsIBA 09/2006
1	Folic Acid AntagonistsIBA 08/2005
1	Quinine (Quinson)FDA Link 01/2005

Therapy/Procedure

9	Therapeutics 01/2017 - 08/2005
1	Aftercare (After-Treatment) 01/2019